298 related articles for article (PubMed ID: 28928044)
1. Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA.
Vicente J; Hosseini M; Johannesen L; Strauss DG
J Electrocardiol; 2017; 50(6):808-813. PubMed ID: 28928044
[TBL] [Abstract][Full Text] [Related]
2. Update on the ECG component of the CiPA initiative.
Vicente J
J Electrocardiol; 2018; 51(6S):S98-S102. PubMed ID: 30121123
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block.
Vicente J; Johannesen L; Hosseini M; Mason JW; Sager PT; Pueyo E; Strauss DG
PLoS One; 2016; 11(12):e0163619. PubMed ID: 28036334
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of multiple algorithms for the measurement of the heart rate corrected JTpeak interval.
Couderc JP; Ma S; Page A; Besaw C; Xia J; Chiu WB; de Bie J; Vicente J; Vaglio M; Badilini F; Babaeizadeh S; Chien CS; Baumert M
J Electrocardiol; 2017; 50(6):769-775. PubMed ID: 29021091
[TBL] [Abstract][Full Text] [Related]
5. The algorithmic performance of J-Tpeak for drug safety clinical trial.
Chien SC; Gregg RE
J Electrocardiol; 2017; 50(6):762-768. PubMed ID: 28942951
[TBL] [Abstract][Full Text] [Related]
6. Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs.
Vicente J; Stockbridge N; Strauss DG
J Electrocardiol; 2016; 49(6):837-842. PubMed ID: 27524478
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.
Vicente J; Johannesen L; Mason JW; Crumb WJ; Pueyo E; Stockbridge N; Strauss DG
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25870186
[TBL] [Abstract][Full Text] [Related]
8. Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk.
Johannesen L; Vicente J; Hosseini M; Strauss DG
PLoS One; 2016; 11(12):e0166925. PubMed ID: 28036330
[TBL] [Abstract][Full Text] [Related]
9. Cardiologist's point of view: Novel ECG biomarkers and in silico models for proarrhythmic risk prediction: Are we ready?
Mason JW
J Electrocardiol; 2017; 50(6):825-827. PubMed ID: 28919218
[TBL] [Abstract][Full Text] [Related]
10. A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium.
Boulay E; Abernathy MM; Chui R; Friedrichs GS; Gendron-Parra N; Greiter-Wilke A; Guillon JM; Koerner JE; Menard A; Steidl-Nichols J; Pierson J; Pugsley MK; Rossman EI; Strauss D; Troncy E; Valentin JP; Wisialowski T; Authier S
Int J Toxicol; 2019; 38(1):23-32. PubMed ID: 30567462
[TBL] [Abstract][Full Text] [Related]
11. Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.
Johannesen L; Vicente J; Mason JW; Sanabria C; Waite-Labott K; Hong M; Guo P; Lin J; Sørensen JS; Galeotti L; Florian J; Ugander M; Stockbridge N; Strauss DG
Clin Pharmacol Ther; 2014 Nov; 96(5):549-58. PubMed ID: 25054430
[TBL] [Abstract][Full Text] [Related]
12. The J to T-peak interval as a biomarker in drug safety studies: A method of accuracy assessment applied to two algorithms.
Chiu WB; de Bie J; Mortara DW
J Electrocardiol; 2017; 50(6):758-761. PubMed ID: 28751012
[TBL] [Abstract][Full Text] [Related]
13. How to determine cardiac ion channels targeted by drugs using the isolated rabbit ventricular wedge model.
Liu G; Liu T; Cohen D; Liu T; Yan GX
J Pharmacol Toxicol Methods; 2016; 81():161-70. PubMed ID: 27195944
[TBL] [Abstract][Full Text] [Related]
14. Differentiating multichannel block on the guinea pig ECG: Use of T
Skinner M; Hale E; Ceuppens P; Pollard C
J Pharmacol Toxicol Methods; 2021; 111():107085. PubMed ID: 34182121
[TBL] [Abstract][Full Text] [Related]
15. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology.
Li Z; Dutta S; Sheng J; Tran PN; Wu W; Chang K; Mdluli T; Strauss DG; Colatsky T
Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004628. PubMed ID: 28202629
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
Crumb WJ; Vicente J; Johannesen L; Strauss DG
J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
[TBL] [Abstract][Full Text] [Related]
17. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the "CiPA" Initiative and Design of a Prospective Clinical Validation Study.
Vicente J; Zusterzeel R; Johannesen L; Mason J; Sager P; Patel V; Matta MK; Li Z; Liu J; Garnett C; Stockbridge N; Zineh I; Strauss DG
Clin Pharmacol Ther; 2018 Jan; 103(1):54-66. PubMed ID: 28986934
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.
Vicente J; Zusterzeel R; Johannesen L; Ochoa-Jimenez R; Mason JW; Sanabria C; Kemp S; Sager PT; Patel V; Matta MK; Liu J; Florian J; Garnett C; Stockbridge N; Strauss DG
Clin Pharmacol Ther; 2019 Apr; 105(4):943-953. PubMed ID: 30447156
[TBL] [Abstract][Full Text] [Related]
20. T vector velocity: A new ECG biomarker for identifying drug effects on cardiac ventricular repolarization.
Bystricky W; Maier C; Gintant G; Bergau D; Kamradt K; Welsh P; Carter D
PLoS One; 2019; 14(7):e0204712. PubMed ID: 31283756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
